PRGTX vs. PRHSX
Compare and contrast key facts about T. Rowe Price Global Technology Fund (PRGTX) and T. Rowe Price Health Sciences Fund (PRHSX).
PRGTX is managed by T. Rowe Price. It was launched on Sep 28, 2000. PRHSX is managed by T. Rowe Price. It was launched on Dec 29, 1995.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PRGTX or PRHSX.
Key characteristics
| PRGTX | PRHSX | |
|---|---|---|
| YTD Return | 33.82% | 13.25% |
| 1Y Return | 48.30% | 19.97% |
| 3Y Return (Ann) | -15.78% | -4.53% |
| 5Y Return (Ann) | 6.53% | 4.76% |
| 10Y Return (Ann) | 2.86% | 3.10% |
| Sharpe Ratio | 2.11 | 1.20 |
| Sortino Ratio | 2.72 | 1.62 |
| Omega Ratio | 1.37 | 1.22 |
| Calmar Ratio | 0.78 | 0.59 |
| Martin Ratio | 9.57 | 5.93 |
| Ulcer Index | 4.97% | 2.91% |
| Daily Std Dev | 22.55% | 14.33% |
| Max Drawdown | -73.10% | -47.79% |
| Current Drawdown | -42.14% | -15.02% |
Correlation
The correlation between PRGTX and PRHSX is 0.67, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
PRGTX vs. PRHSX - Performance Comparison
In the year-to-date period, PRGTX achieves a 33.82% return, which is significantly higher than PRHSX's 13.25% return. Over the past 10 years, PRGTX has underperformed PRHSX with an annualized return of 2.86%, while PRHSX has yielded a comparatively higher 3.10% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
PRGTX vs. PRHSX - Expense Ratio Comparison
PRGTX has a 0.95% expense ratio, which is higher than PRHSX's 0.80% expense ratio.
Risk-Adjusted Performance
PRGTX vs. PRHSX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Global Technology Fund (PRGTX) and T. Rowe Price Health Sciences Fund (PRHSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PRGTX vs. PRHSX - Dividend Comparison
Neither PRGTX nor PRHSX has paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRGTX T. Rowe Price Global Technology Fund | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.08% |
PRHSX T. Rowe Price Health Sciences Fund | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
PRGTX vs. PRHSX - Drawdown Comparison
The maximum PRGTX drawdown since its inception was -73.10%, which is greater than PRHSX's maximum drawdown of -47.79%. Use the drawdown chart below to compare losses from any high point for PRGTX and PRHSX. For additional features, visit the drawdowns tool.
Volatility
PRGTX vs. PRHSX - Volatility Comparison
T. Rowe Price Global Technology Fund (PRGTX) has a higher volatility of 6.18% compared to T. Rowe Price Health Sciences Fund (PRHSX) at 4.16%. This indicates that PRGTX's price experiences larger fluctuations and is considered to be riskier than PRHSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.